
Arvind Dasari, MD, MS, explains how to sequence radioligand therapy, cabozantinib, and everolimus in well-differentiated neuroendocrine tumors.
Therapeutic Approach for Stage 4 Gastric Cancer
A 54-Year-Old Man With Stage IV Gastroesophageal Junction Cancer
January 2018
July 2018




